AU2001292001A1 - Pharmaceutical oxan preparation - Google Patents
Pharmaceutical oxan preparationInfo
- Publication number
- AU2001292001A1 AU2001292001A1 AU2001292001A AU9200101A AU2001292001A1 AU 2001292001 A1 AU2001292001 A1 AU 2001292001A1 AU 2001292001 A AU2001292001 A AU 2001292001A AU 9200101 A AU9200101 A AU 9200101A AU 2001292001 A1 AU2001292001 A1 AU 2001292001A1
- Authority
- AU
- Australia
- Prior art keywords
- oxan
- pharmaceutical
- preparation
- pharmaceutical oxan
- oxan preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0012197A FR2814368B1 (en) | 2000-09-26 | 2000-09-26 | PHARMACEUTICAL PREPARATION BASED ON OXANS |
| PCT/FR2001/002980 WO2002026216A1 (en) | 2000-09-26 | 2001-09-26 | Pharmaceutical oxan preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001292001A1 true AU2001292001A1 (en) | 2002-04-08 |
Family
ID=8854662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001292001A Abandoned AU2001292001A1 (en) | 2000-09-26 | 2001-09-26 | Pharmaceutical oxan preparation |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040022834A1 (en) |
| EP (1) | EP1322298A1 (en) |
| JP (1) | JP2004509916A (en) |
| AU (1) | AU2001292001A1 (en) |
| CA (1) | CA2424949A1 (en) |
| FR (1) | FR2814368B1 (en) |
| WO (1) | WO2002026216A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0221443D0 (en) | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
| CN101460156B (en) * | 2006-05-08 | 2011-06-08 | 帝国制药株式会社 | Transdermal Absorption Preparation of Antidementia Drugs |
| JP6654365B2 (en) * | 2015-06-17 | 2020-02-26 | 日東電工株式会社 | Patch preparation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2698789B1 (en) * | 1992-12-07 | 1995-03-03 | Pf Medicament | Use of idazoxan and its derivatives for the preparation of a medicament intended for the treatment of Parkinson's disease and its evolution. |
| DE4301783C1 (en) * | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermal system per admin. of galanthamine - esp. for treatment of Alzheimer's disease and alcohol addiction |
| FR2706303B1 (en) * | 1993-06-18 | 1995-09-08 | Pf Medicament | Use of Efaroxan and its derivatives for the preparation of a medicament intended for the treatment of Parkinson's disease. |
| US5635204A (en) * | 1994-03-04 | 1997-06-03 | Montefiore Medical Center | Method for transdermal induction of anesthesia, analgesia or sedation |
| US5879701A (en) * | 1997-02-28 | 1999-03-09 | Cygnus, Inc. | Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
| FR2801786B1 (en) * | 1999-12-01 | 2002-03-01 | Fabre Pierre Cosmetique | NOVEL TOPICAL COMPOSITIONS BASED ON IDAZOXAN AND CAFFEINE OR ITS SOLUBLE DERIVATIVES AND THEIR USE AS SLIMMERS AND / OR IN THE TREATMENT OF CELLULITE |
-
2000
- 2000-09-26 FR FR0012197A patent/FR2814368B1/en not_active Expired - Fee Related
-
2001
- 2001-09-26 AU AU2001292001A patent/AU2001292001A1/en not_active Abandoned
- 2001-09-26 EP EP01972214A patent/EP1322298A1/en not_active Withdrawn
- 2001-09-26 US US10/381,801 patent/US20040022834A1/en not_active Abandoned
- 2001-09-26 CA CA002424949A patent/CA2424949A1/en not_active Abandoned
- 2001-09-26 JP JP2002530046A patent/JP2004509916A/en active Pending
- 2001-09-26 WO PCT/FR2001/002980 patent/WO2002026216A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2424949A1 (en) | 2002-04-04 |
| WO2002026216A1 (en) | 2002-04-04 |
| US20040022834A1 (en) | 2004-02-05 |
| FR2814368B1 (en) | 2004-05-07 |
| WO2002026216A8 (en) | 2003-01-16 |
| EP1322298A1 (en) | 2003-07-02 |
| JP2004509916A (en) | 2004-04-02 |
| FR2814368A1 (en) | 2002-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001269529A1 (en) | Medicine comprising dicyanopyridine derivative | |
| AU781269C (en) | Pharmaceutical compositions | |
| AU1071301A (en) | Pharmaceutical compounds | |
| AU2001240856A1 (en) | Capsules | |
| AU2002222853A1 (en) | Therapeutic compounds | |
| AU2001250420A1 (en) | Pharmaceutical compositions | |
| AU2001274307A1 (en) | Pharmaceutical compositions | |
| AU2001269508A1 (en) | Drugs or cosmetics | |
| AU2001262691A1 (en) | Cosmetic preparation | |
| AU2001240838A1 (en) | Capsules | |
| AU2001248943A1 (en) | Pharmaceutical curative compound | |
| AU2001273919A1 (en) | Pharmaceutical compositions | |
| AU2002221099A1 (en) | Combination drugs | |
| AUPQ761100A0 (en) | Lipophilic medicament | |
| AU2001291690A1 (en) | Drugs for sex dysfunctions | |
| AU2001232244A1 (en) | Drug comprising combination | |
| AU5722900A (en) | Pharmaceutical compounds | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU2001292301A1 (en) | Novel drugs for liver diseases | |
| AU2001288102A1 (en) | Solid preparations | |
| AU2001272718A1 (en) | Medicaments | |
| AU2001272427A1 (en) | Solid preparations | |
| AU2001292578A1 (en) | Pharmaceutical compounds | |
| AU2001292001A1 (en) | Pharmaceutical oxan preparation | |
| AU3586401A (en) | Pharmaceutical composition |